Landos Biopharma, Inc. Quarterly Depreciation in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Landos Biopharma, Inc. annual/quarterly Depreciation history and growth rate from Q1 2021 to Q1 2023.
  • Landos Biopharma, Inc. Depreciation for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Landos Biopharma, Inc. Depreciation for the twelve months ending March 31, 2023 was $224K, a 55.7% decline year-over-year.
  • Landos Biopharma, Inc. annual Depreciation for 2023 was $0.000, a 100% decline from 2022.
  • Landos Biopharma, Inc. annual Depreciation for 2022 was $577K, a 194% increase from 2021.
  • Landos Biopharma, Inc. annual Depreciation for 2021 was $196K, a 43.1% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $224K $0 -$353K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $577K $0 -$55K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $632K $0 -$48K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $680K $224K +$174K +348% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $506K $353K +$310K +721% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $196K $55K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $48K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $50K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $43K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.